DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo


company name or ticker

Intrexon (XON) Catches Eye: Stock Adds 11.5% in Session - Tale of the Tape

Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk

Wednesday 3/5 Insider Buying Report: XON, CLGX

How Designer Microbes and the Organism Industry Will Reshape Our World

Many investors are captivated by the future of companies such as Tesla Motors and 3-D Systems -- and the potential creation of shareholder value on a scale that will be difficult to match. But are investors overlooking an even more promising industry with a brighter future?

JPMorgan Healthcare Conference 2014: Where To Find Ideas For The Coming Year

Intrexon: Living Better Through Synthetic Biology?

3 Synthetic Biology Stocks That Can Help You Grow in 2014 (and Beyond)

Large-scale genome editing can create entirely new organisms, but it can also create a number of growth opportunities for your portfolio. Here's how Agilent Technologies, Intrexon, and Solazyme can keep your portfolio chugging along in 2014.

Daniel Loeb Comments on Intrexon Corporation

Is This the Top for Intrexon (XON)? - Tale of the Tape

5 Unbelievable (but Real) Technologies Made Possible by Synthetic Biology

The synthetic biology industry has erupted in recent years. The technological breakthroughs can touch numerous industries, from health care to marijuana production.
See More Articles...